You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
希瑪眼科(03309.HK)年度由盈轉虧624.6萬港元
格隆匯 03-31 16:55

格隆匯3月31日丨希瑪眼科(03309.HK)發佈公吿,截至2020年12月31日止年度,公司收入7億港元,同比增長21.4%;公司擁有人應占虧損624.6萬港元,上年同期溢利4143.5萬港元;每股虧損0.57港仙。

監於優質醫療服務的需求日益增加及公司於香港的衞星診所網絡佈局完善,香港收益增長19.3%至3.4億港元。此外,截至2020年12月31日止年度,中國內地營運收益以港元計錄得23.5%增幅,主要由於昆明及上海眼科醫院的收益增長強勁。以港元呈報時,人民幣貶值令公司的收益增長有所下降。以人民幣計,公司於中國內地的收益較截至2019年12月31日止年度增長24.6%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account